US Broker Ratings

Wave Life Sciences Ltd. (WVE) Stock Analysis: Unpacking the 177.70% Potential Upside in Biotech Innovation

Wave Life Sciences Ltd. (WVE), a Singapore-based biotechnology company, is capturing the attention of investors with its groundbreaking RNA medicines and a staggering potential upside of..

NeoGenomics, Inc. (NEO) Stock Analysis: A Look at Its 28.7% Potential Upside and Analyst Sentiment

For investors keen on the healthcare sector, NeoGenomics, Inc. (NASDAQ: NEO) presents a compelling opportunity with its focus on cancer diagnostics and research. Headquartered in Fort..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Exploring a 34% Potential Upside in the Healthcare Sector

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a company at the forefront of the medical devices industry, is capturing attention with its significant potential upside of 34.02%...

agilon health, inc. (AGL) Stock Analysis: Eyeing a 33.75% Upside in a Challenging Market Landscape

agilon health, inc. (NYSE: AGL) is a player in the healthcare sector, specifically within the medical care facilities industry. Based in Westerville, Ohio, the company focuses..

U.S. Physical Therapy, Inc. (USPH): Investor Outlook on Strong Revenue Growth and Upside Potential

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, is making waves with its impressive revenue growth and a substantial potential upside..

Evolent Health, Inc. (EVH) Stock Analysis: A Potential 76% Upside with Strong Buy Ratings

Evolent Health, Inc. (NYSE: EVH), a key player in the healthcare sector, is garnering significant attention from investors with its focus on specialty care management services..

Harrow, Inc. (HROW) Stock Analysis: A 37% Potential Upside Captivates Investors

In the bustling realm of the healthcare sector, Harrow, Inc. (NASDAQ: HROW) stands out as a burgeoning player in the specialty and generic drug manufacturing industry...

Pacira BioSciences, Inc. (PCRX) Investor Outlook: A 14.44% Upside Amidst Healthcare Innovations

Pacira BioSciences, Inc. (NASDAQ: PCRX), a prominent player in the healthcare sector, stands at the forefront of non-opioid pain management solutions. With a market capitalization of..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A Biotech Prospect with a 222% Upside Potential

Investors looking for promising opportunities in the biotechnology sector may find ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) an intriguing prospect. With a market capitalization of $968.5 million,..

Immunocore Holdings plc (IMCR) Growth Potential: Analyst Ratings Suggest an 81% Upside

Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biotechnology company, has captured investor attention with its promising pipeline of immunotherapies targeting cancer, infectious, and autoimmune diseases. As..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: 178.4% Potential Upside Sparks Investor Interest

Dyne Therapeutics, Inc. (NASDAQ: DYN) is making waves in the biotechnology sector with its ambitious approach to tackling neuromuscular diseases. This clinical-stage company, headquartered in Waltham,..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 21.35% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, offers a compelling investment opportunity..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 55% Upside Potential

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is capturing investor attention with a robust potential upside of approximately 55.28%. Specializing in medical..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Buy Ratings and 14.22% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has emerged as a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 76% Potential Upside in the Biotechnology Sector

Investors with an eye on the healthcare sector might want to pay close attention to MiMedx Group, Inc. (NASDAQ: MDXG), a company entrenched in the biotechnology..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Unpacking a 9.16% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a notable player in the medical care facilities industry, offers a compelling investment narrative with a promising 9.16% potential upside...

The Pennant Group, Inc. (PNTG) Investor Outlook: Exploring a 33% Potential Upside

The Pennant Group, Inc. (NASDAQ: PNTG), a key player in the U.S. healthcare sector, commands attention with its focus on home health, hospice services, and senior..

Novavax, Inc. (NVAX) Investor Outlook: Exploring a 45.86% Upside Potential

Novavax, Inc. (NVAX), a prominent player in the biotechnology sector, has been a focal point of attention for investors, particularly following the development and commercialization of..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 51% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector, particularly within the medical devices industry, presents a compelling opportunity for investors looking to capitalize..

Immunovant, Inc. (IMVT): Investor Outlook on a Potential 148% Upside in Biotech

Immunovant, Inc. (IMVT) stands as a notable player in the biotechnology sector, specifically focusing on the development of monoclonal antibodies to tackle autoimmune diseases. Based in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds